News | April 07, 2022
Indian pharma growth likely to moderate in FY23: ICRA
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
Drones will be used in the Gurugram and Mumbai region to transport pathology samples
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
The plant is scheduled to come on stream in September 2024
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Technology Development Board supports commercialisation of Metal Injection Molding of implants
New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Subscribe To Our Newsletter & Stay Updated
